openPR Logo
Press release

Peptide-based Drug market size is estimated to be worth US$ 34550 million in 2022 and is forecast to a readjusted size of US$ 58070 million by 2028 with a CAGR of 9.0% - Valuates Reports

02-14-2023 11:48 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Peptide-based Drug market size is estimated to be worth US$ 34550

Due to the COVID-19 pandemic, the global Peptide-based Drug market size is estimated to be worth US$ 34550 million in 2022 and is forecast to a readjusted size of US$ 58070 million by 2028 with a CAGR of 9.0% during the review period.

Get Sample Report - https://reports.valuates.com/request/sample/QYRE-Auto-30R5170/Global_Peptide_based_Drug_Market_Size_Status_and_Forecast_2021_2027

Peptide-based Drug Market Insights
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.

Peptide-based Drug Market Analysis
This report focuses on global and United States Peptide-based Drug market, also covers the segmentation data of other regions in regional level and county level.

While by Application, Cancer was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Peptide-based Drug market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.

Peptide-based Drug Market Scope and Market Size
Peptide-based Drug market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Peptide-based Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Peptide-based Drug market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Peptide-based Drug Market Segment by Type
Injection
Oral
Other

Peptide-based Drug Market Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other

Get Detailed Report - https://reports.valuates.com/market-reports/QYRE-Auto-30R5170/global-and-united-states-peptide-based-drug

Similar Reports

Liraglutide Market - https://reports.valuates.com/market-reports/QYRE-Auto-29O4198/global-liraglutide

Anticoagulant Drugs market - https://reports.valuates.com/market-reports/QYRE-Auto-4Y11406/global-anticoagulant-drugs-sales

Peptide Based Infection Therapeutics Market - https://reports.valuates.com/market-reports/QYRE-Auto-13N6251/global-peptide-based-infection-therapeutics

Pharmaceutical Aseptic Filling Machine Market - https://reports.valuates.com/market-reports/QYRE-Auto-16F9006/global-pharmaceutical-aseptic-filling-machine

Valuates Reports
sales@valuates.com
For U.S. Toll Free Call +1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp : +91-9945648335

Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
Linkedin - https://in.linkedin.com/company/valuatesreports
Facebook - https://www.facebook.com/valuatesreports/

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peptide-based Drug market size is estimated to be worth US$ 34550 million in 2022 and is forecast to a readjusted size of US$ 58070 million by 2028 with a CAGR of 9.0% - Valuates Reports here

News-ID: 2929200 • Views:

More Releases from Valuates Reports

Semi-Insulating Silicon Carbide Wafer Market Share Driven by 5G Expansion and Ad …
Semi-Insulating Silicon Carbide Wafer Market Size The global market for Semi-Insulating Silicon Carbide Wafer was valued at US$ 284 million in the year 2024 and is projected to reach a revised size of US$ 595 million by 2031, growing at a CAGR of 11.3% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-18Y11148/Global_Semi_Insulating_Silicon_Carbide_Wafer_Market_Research_Report_2022 The Semi-Insulating Silicon Carbide Wafer Market is gaining strong momentum as wide bandgap semiconductor materials become essential to high-frequency, high-power applications in
4 Inches Semi-Insulating Silicon Carbide Wafer Market Share Driven by Expansion …
4 Inches Semi-Insulating Silicon Carbide Wafer Market Size The global market for 4 Inches Semi-Insulating Silicon Carbide Wafer was valued at US$ 88.1 million in the year 2024 and is projected to reach a revised size of US$ 155 million by 2031, growing at a CAGR of 8.5% during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-35E15164/Global_4_Inches_Semi_Insulating_Silicon_Carbide_Wafer_Market_Research_Report_2023 The 4 Inches Semi-Insulating Silicon Carbide Wafer Market is witnessing growing market size as semiconductor manufacturers increasingly adopt
300 mm Wafer Front Opening Unified Pod Market Share Driven by Increasing Automat …
300 mm Wafer Front Opening Unified Pod Market The global market for 300 mm Wafer Front Opening Unified Pod was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-39P12958/Global_300_mm_Wafer_Front_Opening_Unified_Pod_Market_Research_Report_2023 The 300 mm Wafer Front Opening Unified Pod Market is experiencing strong market growth as semiconductor manufacturers prioritize advanced wafer
Clean Transfer Robot Market Share Driven by Increasing Automation in Semiconduct …
Clean Transfer Robot Market The global market for Clean Transfer Robot was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-23W12497/Global_Clean_Transfer_Robot_Industry_Research_Report_Growth_Trends_and_Competitive_Analysis_2022_2028 The Clean Transfer Robot Market is witnessing considerable market growth as semiconductor and flat panel display manufacturers adopt advanced robotic handling systems to enhance production reliability, eliminate contamination,

All 5 Releases


More Releases for Peptide

Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be? In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights: • Global Peptide Cancer Drug Market Insight By Region & Indication • Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion • Approved Peptide Cancer Drugs: > 30 Drugs • Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis • Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase • Insight On Peptide Cancer Drugs In Clinical Trials: >
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). [https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established